stockrow
Friday 6 November 2026
Export MDLN’s income statement to Excel — free account
Medline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
38.95
0.81
−2.04%
Follow MDLN
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 3.18% | 0.00% | 0.00% | — |
+4 more TTM periods Free account |
|
| 1.49% | 3.58% | 2.58% | 0.00% | ||
ROIC |
17.80% | 19.94% | 19.84% | 0.00% | |
Return on Tangible Assets |
3.97% | 5.13% | 7.21% | 0.00% | |
Average Days of Receivables |
45.14 | 44.98 | 46.78 | 0.00 | |
Free Cash Flow per Share |
3.54 | 2.69 | 2.79 | 4.18 | |
Free Cash Flow |
3,101.00 | 2,304.00 | 2,284.00 | 3,383.00 | |
Capital Expenditures |
(795.00) | (764.00) | (751.00) | (1,009.00) | |
| Other line items | |||||
Cash ROIC |
9.70% | 6.71% | 6.69% | 10.01% | |
Accounts Receivable Turnover |
8.75 | 0.00 | 0.00 | — | |
Accounts Payable Turnover |
21.07 | 0.00 | — | — | |
Inventory Turnover |
4.73 | 0.00 | — | — | |
Average Days of Payables |
20.16 | 18.32 | 0.00 | 0.00 | |
Days of Inventory on Hand |
80.13 | 81.93 | 0.00 | 0.00 | |
Tax Rate |
(0.03) | (0.02) | 0.00 | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
15.82% | 15.71% | 0.00% | — | |
Share Based Compensation of Revenue |
0.31% | 0.29% | 0.00% | — | |
Interest Coverage |
15.28 | 13.44 | — | — | |
Operating CF/Net income |
6.88 | 4.36 | 3.14 | 0.00 | |
Depreciation/Fixed assets |
0.00 | 0.40 | 0.39 | 0.56 | |
Capex/Depreciation |
0.00 | (0.41) | (0.40) | (0.38) | |
Revenue per Share |
35.00 | 34.67 | 35.00 | 0.00 | |
Operating CF per Share |
4.45 | 3.58 | 3.71 | 5.42 | |
Capex per Share |
(0.91) | (0.89) | (0.92) | (1.25) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.00 |
Columns are period end dates · fundamentals updated 4 Nov 2026